Research programme: anti-gastrin receptor radiolabelled antibodies - Aphton
Alternative Names: Anti-gastrin receptor radiolabelled antibodies research programme - AphtonLatest Information Update: 05 Nov 2009
At a glance
- Originator Aphton Corporation
- Class Antibodies; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 05 Nov 2009 Discontinued - Preclinical for Solid tumours in USA (unspecified route)
- 18 May 2005 Preclinical trials in Solid tumours in USA (unspecified route)
- 03 Apr 2003 No development reported - Preclinical for Solid tumours in USA (unspecified route)